HMG-CoA Reductase Inhibitor [EPC]

334489 reported adverse events

Drugs of this class: SIMVASTATIN LOVASTATIN EZETIMIBE AND SIMVASTATIN ATORVASTATIN CALCIUM PITAVASTATIN MAGNESIUM ROSUVASTATIN

These side effects are most commonly reported by patients taking drugs of the HMG-CoA Reductase Inhibitor [EPC] class:

# Side effect Count
0 FATIGUE 18004
1 NAUSEA 16854
2 DRUG INEFFECTIVE 16754
3 DYSPNOEA 16134
4 DIARRHOEA 15123
5 DIZZINESS 14141
6 ASTHENIA 12139
7 PAIN 12095
8 FALL 11692
9 HEADACHE 11311
See all common reactions for HMG-CoA Reductase Inhibitor [EPC]

Drugs of the HMG-CoA Reductase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IMMUNE-MEDIATED NECROTISING MYOPATHY 251 0.4580
1 IMMUNE-MEDIATED MYOSITIS 321 0.3821
2 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 246 0.2645
3 MYOPATHY 1716 0.2562
4 HYPERPARATHYROIDISM SECONDARY 549 0.2465
5 NEPHROGENIC ANAEMIA 975 0.2314
6 RHABDOMYOLYSIS 7135 0.2223
7 REBOUND ACID HYPERSECRETION 536 0.1843
8 POLYMYOSITIS 206 0.1456
9 SEDATION COMPLICATION 213 0.1448
See all enriched reactions for HMG-CoA Reductase Inhibitor [EPC]